Medical News on Cancer
Potential treatment for autoimmune disease - marijuana
Jun 04, 2014
A team of University of South Carolina researchers led by Mitzi Nagarkatti, Prakash Nagarkatti and Xiaoming Yang have discovered a novel pathway through which marijuana can suppress the body's immune... Read More
In metastatic prostate cancer, drug combination extends survival by more than a year
Jun 04, 2014
Men with newly diagnosed metastatic, hormone-sensitive prostate cancer lived more than a year longer when they received a chemotherapy drug as initial treatment instead of waiting for the disease to... Read More
VELCADE Phase 3 study results presented for patients with mantle cell lymphoma
Jun 03, 2014
Millennium: The Takeda Oncology Company has announced results from the primary analysis of an international, randomized Phase 3 study that showed treatment with a VELCADE® (bortezomib)-based... Read More
Risk of secondary cancers increased following radiation for prostate cancer
Jun 03, 2014
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study from the University of Michigan... Read More
Targeting cancer stem cells: results in phase I trial of OMP-54F28
Jun 03, 2014
At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an... Read More
Support of ibrutinib strengthened as second-line therapy for CLL by phase 3 study
Jun 03, 2014
In a head-to-head comparison of two Food and Drug Administration-approved drugs for the treatment of relapsed chronic lymphocytic leukemia (CLL), ibrutinib significantly outperformed ofatumumab as a... Read More
Volatile organic compounds in exhaled breath show presence and stage of lung cancer
Jun 03, 2014
Results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show that a test of organic compounds in exhaled... Read More
New targetable form of disease revealed by responses with crizotinib in MET-amplified lung cancer
Jun 03, 2014
A study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2014 reports the results of a first-in-human, phase 1 dose escalation trial of crizotinib (XALKORI) in 14 patients... Read More
Promising response to new combination therapy by patients with metastatic colon cancer
Jun 03, 2014
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a... Read More
More patients with ovarian cancer are receiving chemotherapy before surgery
Jun 03, 2014
The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer... Read More
Previous Page Next Page